Project description:Recent progress in unbiased metagenomic next-generation sequencing (mNGS) allows simultaneous examination of microbial and host genetic material in a single test. Leveraging affordable bronchoalveolar lavage fluid (BALF) mNGS data, we employed machine learning to create a diagnostic approach distinguishing lung cancer from pulmonary infections, conditions prone to misdiagnosis in clinical settings. This prospective study analyzed BALF-mNGS data from lung cancer and pulmonary infection patients, delineating differences in DNA/RNA microbial composition, bacteriophage abundances, and host responses, including gene expression, transposable element levels, immune cell composition, and tumor fraction derived from copy number variation (CNV). Integrating these metrics into a host/microbe metagenomics-driven machine learning model (Model VI) demonstrated robustness, achieving an AUC of 0.87 (95% CI = 0.857-0.883), sensitivity = 73.8%, and specificity = 84.5% in the training cohort, and an AUC of 0.831 (95% CI = 0.819-0.843), sensitivity = 67.1%, and specificity = 94.4% in the validation cohort for distinguishing lung cancer from pulmonary infections. The application of a rule-in and rule-out strategy-based composite predictive model significantly enhances accuracy (ACC) in distinguishing between lung cancer and tuberculosis (ACC=0.913), fungal infection (ACC=0.955), and bacterial infection (ACC=0.836). These findings highlight the potential of cost-effective mNGS-based analysis as a valuable tool for early differentiation between lung cancer and pulmonary infections, offering significant benefits through a single comprehensive testing.
2024-01-08 | GSE252118 | GEO
Project description:Metagenomic Next-Generation Sequencing (mNGS) of Clinical Samples
| PRJNA588503 | ENA
Project description:metagenomic next-generation sequencing (mNGS) of female urine
Project description:Metagenomic next-generation sequencing (mNGS) is increasingly being applied in clinical laboratories for unbiased culture-independent diagnosis. We use the mNGS as a routine diagnostic test in clinical.
| PRJEB48135 | ENA
Project description:data of pleural effusion metagenomic next-generation sequencing (mNGS)
| PRJNA1085983 | ENA
Project description:Clinical diagnostic application of metagenomic next-generation sequencing in children with severe pneumonia
| PRJNA572371 | ENA
Project description:Diagnostic value of whole blood metagenomic next-generation sequencing in bloodstream infectious diseases
| PRJNA864580 | ENA
Project description:Metagenomic Next-generation Sequencing Technology (mNGS) as An Emerging Effective Diagnostic Tool for Talaromycosis in HIV-negative Patients
| PRJNA817336 | ENA
Project description:Metagenomic next-generation sequencing (mNGS) of the chicken ileum and cecum